Concepedia

James E. Polli

JE

Statistics

Publications

134

Citations

6.6K

H-Index

39

Active since

1996

Affiliations

University of Maryland, Baltimore(Current)

Center for Drug Evaluation and Research

United States Food and Drug Administration

AstraZeneca (Sweden)

International Pharmaceutical Federation

James E. Polli is an author at University of Maryland, Baltimore specializing in pharmacology, pharmacy, and bioavailability.

ORCID

Publications per year

1996–2024

134

Publications

134

Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions

Lawrence X. Yu, Gordon L. Amidon, James E. Polli et al. · Pharmaceutical Research · 2002 · 565 citations · Full text

, , +11

Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers

Bhagwant Rege, Joseph P. Y. Kao, James E. Polli · European Journal of Pharmaceutical Sciences · 2002 · 503 citations

, , +16

Methods to Compare Dissolution Profiles and a Rationale for Wide Dissolution Specifications for Metoprolol Tartrate tablets†

James E. Polli, Gurvinder Singh Rekhi, Larry L. Augsburger et al. · Journal of Pharmaceutical Sciences · 1997 · 333 citations

, , +16

Effect of Common Excipients on Caco-2 Transport of Low-Permeability Drugs

Bhagwant Rege, Lawrence X. Yu, Ajaz Hussain et al. · Journal of Pharmaceutical Sciences · 2001 · 206 citations

, , +16

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Diclofenac Sodium and Diclofenac Potassium

Bancha Chuasuwan, V. Binjesoh, James E. Polli et al. · Journal of Pharmaceutical Sciences · 2008 · 179 citations · Full text

, , +16

1–5 of 134